Which country is the world’s top exporter of drugs?
The US has the world top exporters of drugs, with the US leading the pack.
China has the third-largest number of drug imports.
The report shows that the world economy is still a net importer of prescription drugs, accounting for $14.2 trillion in 2014.
The US accounted for more than 80 percent of that, accounting at $7.6 trillion.
India followed close behind at $6.5 trillion.
The rest of the world accounted for less than 10 percent.
The new report is the latest in a series that assesses the health, economic and political challenges facing the global economy.
The U.S. has been the world leader in pharmaceuticals since the 1960s, with exports of about $13 trillion annually.
China was the first country to export its own drugs, and its exports to the U.K. and Canada increased substantially in recent years.
Canada also has a long history of drug manufacturing and exports, with more than $1 trillion in exports in 2014, according to the report.
The United States has been a net exporter since at least 2006.
China’s share of global drug exports fell from 10.4 percent in 2006 to just 4.6 percent in 2014 and India has been growing its drug exports as a share of its economy.
India exported nearly $1.5 billion in drugs in 2014 that were sold in the U-K.
That’s down from more than a $2 billion in 2006, according the report, which was based on U.N. data.
The authors of the report argue that the economic and social costs of drug shortages have been growing at an accelerating pace.
They also point to the need for more global cooperation to address the global drug shortage.
“There’s a growing recognition that drug shortages are a global problem and an issue of international importance,” said Andrew M. Risbey, professor of economics and management at the University of Chicago.
“We’re not at a tipping point yet, but we are seeing the signs of a trend that will have a very significant impact on the global health and economic outlook.”
The report does not include countries like Vietnam and Saudi Arabia, which have large drug stockpiles.
Risks for drug shortages were also highlighted in the report in the form of more dangerous opioid addiction and a lack of effective and affordable treatment options.
“A huge amount of resources and money are being spent to fight the opioid epidemic in this country and it’s hard to see how that’s going to yield much of a reduction in drug use,” said Risbekys.
“Even if we did end up with a lower number of overdoses, it’s unlikely that it would lead to significant change in the overall global drug use, as the country would continue to import far more drugs than it exports.”